Advertisement

Topics

Scancell Limited Company Profile

09:06 EST 18th November 2018 | BioPortfolio

Scancell Ltd is a company focused on the discovery and development of products that harness the immune system in a unique way to treat or prevent cancer. Founded in 1997 as a spin-out from the University of Nottingham, Scancell is based in state-of-the-art facilities at the BioCity innovation and technology centre, Nottingham. The Company, which currently employs 12 staff, has secured £4.7million of private equity and commercial funding to date. Scancell is focused in two areas: therapeutic monoclonal antibodies and cancer vaccines. Scancell’s first antibody, an EGFr antibody licensed to ISU Abxis, is expected to enter clinical trials within 12 months. Scancell has two further direct killing therapeutic antibodies against proprietary targets in preclinical development – both products are expected to be in clinical testing by the end of 2006. In addition, Scancell has two further vaccine products in development based on its proprietary ImmunoBody® vaccine technology.

Location

BioCity
Pennyfoot Street
Nottingham
Nottinghamshire
NG1 1GF
United Kingdom

Contact

Phone: 0115 912 4311
Fax: 0115 912 4317
Email: lindy.durrant@nottingham.ac.uk


News Articles [43 Associated News Articles listed on BioPortfolio]

Scancell expands cancer research deal with Karolinska Institute

UK immunotherapy biotech Scancell Holdings has extended its strategic research collaboration with the Rheumatology Unit at the Karolinska Institute Sweden, to explore the potential of its tech in a wi...

Scancell’s Modi-2 anti-cancer vaccine shows potential in pre-clinical studies

Modi-2 is the second vaccine developed from the Moditope platform after Modi-1, and Scancell thinks each one has the potential to treat different types of cancer

Scancell Holdings granted European patent for Moditope

AIM-quoted immunotherapies developer Scancell Holdings has been granted a European patent for its Moditope platform by the European Patent Office. Coming into effect on 13 June, the patent will pro...

British Biotech Raises £8.7M for White Blood Cell-Activating Cancer Vaccines

Scancell has raised £8.7M (€10M) in a public offering, which will be used to advance the clinical development of its cancer vaccine portfolio. Scancell has raised substantial funding on the AIM se...

Scancell Holdings inks drug delivery technology deal

It has exercised an option on TriGrid, which was developed by Ichor Medical Systems

Scancell Holdings part of the new cancer revolution

The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology

Scancell says it is working closely with US regulators ahead of phase II study of cancer immunotherapy

The UK group is planning to use its SCIB1 in harness with Merck’s Keytruda to treat patients with advanced melanoma

Scancell Holdings extends collaboration with Sweden's Karolinska Institute

The company first teamed up with Sweden's world-leading medical research university two years ago

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [87 Associated Companies listed on BioPortfolio]

Scancell Holdings Plc

Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases based on its groundbreaking ImmunoBody® technology platform. Scancellâ€...

Scancell Limited

Scancell Ltd is a company focused on the discovery and development of products that harness the immune system in a unique way to treat or prevent cancer. Founded in 1997 as a spin-out from the Univers...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Scancell Limited" on BioPortfolio

We have published hundreds of Scancell Limited news stories on BioPortfolio along with dozens of Scancell Limited Clinical Trials and PubMed Articles about Scancell Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scancell Limited Companies in our database. You can also find out about relevant Scancell Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record